Matches in Wikidata for { <http://www.wikidata.org/entity/Q91947738> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q91947738 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q91947738 description "im Dezember 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91947738 description "scientific article published on 13 December 2019" @default.
- Q91947738 description "wetenschappelijk artikel" @default.
- Q91947738 description "наукова стаття, опублікована 13 грудня 2019" @default.
- Q91947738 name "Isatuximab plus carfilzomib/dexamethasone versus carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma: IKEMA Phase III study design" @default.
- Q91947738 name "Isatuximab plus carfilzomib/dexamethasone versus carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma: IKEMA Phase III study design" @default.
- Q91947738 type Item @default.
- Q91947738 label "Isatuximab plus carfilzomib/dexamethasone versus carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma: IKEMA Phase III study design" @default.
- Q91947738 label "Isatuximab plus carfilzomib/dexamethasone versus carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma: IKEMA Phase III study design" @default.
- Q91947738 prefLabel "Isatuximab plus carfilzomib/dexamethasone versus carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma: IKEMA Phase III study design" @default.
- Q91947738 prefLabel "Isatuximab plus carfilzomib/dexamethasone versus carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma: IKEMA Phase III study design" @default.
- Q91947738 P1433 Q91947738-BE7661BD-C2AC-4B94-A1AE-1C8D4E823B7B @default.
- Q91947738 P1476 Q91947738-9F62BDC2-8CBF-4CA8-928F-D51A604065B8 @default.
- Q91947738 P2093 Q91947738-06FA1568-1D9E-46A6-897B-D1907C6873C2 @default.
- Q91947738 P2093 Q91947738-5162B115-45D5-4FE3-85E6-63650FD56A5F @default.
- Q91947738 P2093 Q91947738-61427054-E180-44AB-B28C-BE69E509587C @default.
- Q91947738 P2093 Q91947738-EA166A15-FEB2-40AA-B150-E6FC09222EA5 @default.
- Q91947738 P2093 Q91947738-F746A06D-01FF-4893-9D0A-C3AF406C4A16 @default.
- Q91947738 P2093 Q91947738-FED3CD75-6DA7-4CC0-9CE2-679770C148C7 @default.
- Q91947738 P31 Q91947738-00899576-E0CF-4A1A-B4DE-BE6E17482DA3 @default.
- Q91947738 P356 Q91947738-DC6F6CD2-AD67-46BE-A1E8-575C05A2FE11 @default.
- Q91947738 P50 Q91947738-E129CF62-AB5A-4954-9348-111B2AA555BA @default.
- Q91947738 P577 Q91947738-FB2DAD91-E104-48BA-8D08-DEF82C8483C4 @default.
- Q91947738 P698 Q91947738-DECB5B54-859F-45C8-A34B-2A221BAC679D @default.
- Q91947738 P921 Q91947738-DCC47033-4D39-46D2-9128-32450DB1C811 @default.
- Q91947738 P356 FON-2019-0431 @default.
- Q91947738 P698 31833394 @default.
- Q91947738 P1433 Q2781597 @default.
- Q91947738 P1476 "Isatuximab plus carfilzomib/dexamethasone versus carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma: IKEMA Phase III study design" @default.
- Q91947738 P2093 "Gaëlle Asset" @default.
- Q91947738 P2093 "Joseph Mikhael" @default.
- Q91947738 P2093 "Kwee Yong" @default.
- Q91947738 P2093 "Marie-Laure Risse" @default.
- Q91947738 P2093 "Meletios A Dimopoulos" @default.
- Q91947738 P2093 "Thomas Martin" @default.
- Q91947738 P31 Q13442814 @default.
- Q91947738 P356 "10.2217/FON-2019-0431" @default.
- Q91947738 P50 Q87734443 @default.
- Q91947738 P577 "2019-12-13T00:00:00Z" @default.
- Q91947738 P698 "31833394" @default.
- Q91947738 P921 Q422252 @default.